Articles Tagged With:
-
Surgical Management of Infective Endocarditis
SOURCES: Chu VH, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: A prospective study from the international collaboration on endocarditis. Circulation 2015;131:131-140; Erbel R. The new strategy in infective endocarditis: Early surgery based on early diagnosis: Are we too late when early surgery is best? Circulation 2015;131:121-123. -
HAI report: Hard-won gains fall short of ‘ambitious’ targets
Nobody said this was going to be easy. While much progress has been made, the unvarnished truth is that not one of the national health care associated infection (HAI) five-year reduction goals from 2009 to 2013 were met, the Centers for Disease Control and Prevention reports.1
-
ED Push - March 2015 First Issue
-
Non-pharmaceutical Techniques Can Decrease Delirium
Here are some non-pharmaceutical remedies a new study recommends.
-
Physician Divorce Rates Lower Than Most Other Healthcare Professionals
A recent analysis on divorce rates among healthcare professionals in the U.S. paints a fairly rosy picture of home life for physicians.
-
Electronic Health Records Use Nearly Doubles in EDs
Keeping track of everything in emergency medicine sure was a lot different in 2006.
-
A New Oral Treatment for Hyperkalemia: Patiromer
Patiromer (PAT) is an oral non-absorbable polymer that works by binding potassium (K+) in exchange for calcium in the distal colon. Currently available oral treatments for hyperkalemia are burdened by GI adverse effects as well as limited efficacy. Hyperkalemia is particularly problematic in chronic kidney disease (CKD), which may be compounded by the need to administer ACE inhibitors or angiotensin II receptor blockers (ARB).
-
Ambulatory BP Monitoring
The benefits of hypertension treatment (HTN), often cited as a 25% reduction in myocardial infarction, 40% reduction in stroke, and 50% reduction in heart failure, have generally been demonstrated in clinical trials based on an office blood pressure measurement. Since a substantial minority of patients enrolled in HTN trials — approximately one-third according to numerous estimates — ultimately turn out to have white coat HTN (wc-HTN), we may be underestimating the actual benefits of HTN treatment. Patients with wc-HTN do not suffer the same increased risk of cardiovascular events as HTN patients; hence, their inclusion in HTN trials “dilutes” treatment effects.
-
The Vitals - March 2015
-
Options Expand for Women
The FDA has approved a new intrauterine device that will be offered on the commercial market and at a reduced cost to some public health clinics.